Panel Discussion

Tuesday, March 11, 2025

12:12 PM - 12:30 PM ET

Panel Moderator(s)

Raoul I. Bonan, MD, FSCAI

Associate Professor of Medicine
Univerty of Montreal
Montreal, Quebec, Canada

Disclosure information not submitted.
Yair Feld, MD, PhD

Director -Interventional cardiology
Tzafon Medical Center (Poriya), Israel

No relationships to disclose
Steven L. Goldberg, MD, FSCAI, FACC

Interventional Cardiologist
SL Goldberg MD A Medical Corporation
Monterey, California, United States

No relationships to disclose

Panel Discussant(s)

Jeff W. Chambers, MD, FSCAI, FACC

Director of the percutaneous Coronary Interventions
Metropolitian Heart and Vascular Institute
Minneapolis, Minnesota, United States

No relationships to disclose
Georges Ephrem, MD, MSc, FACP, FACC, FSCAI

Assistant Professor
UTHSC
Memphis, Tennessee, United States

Disclosure information not submitted.
Nicolo Piazza, MD, PhD

Assistant Professor
McGill University Health Center
Montreal, Quebec, Canada

Disclosure(s): No financial relationships to disclose
Ramon Quesada, MD, FACP, FACC, FSCAI

Medical Director of Interventional Cardiology, Structural Heart & Cardiac Research
Miami Cardiac & Vascular Institute
Miami, Florida, United States

No relationships to disclose
Michael J. Reardon, MD

Professor and Allison Family Distinguished Chair of Cardiovascular Research
Houston Methodist DeBakey Heart & Vascular Center
Houston, Texas, United States

No relationships to disclose
Toby Rogers, MD, PhD

Associate Professor of Medicine (Cardiology) and Scientific Lead for Structural Heart Disease
Georgetown University and MedStar Washington Hospital Center
Washington, District of Columbia, United States

Disclosure information not submitted.
Horst Sievert, MD, FSCAI, FACC, FESC

Director
CardioVascular Center Frankfurt CVC
Frankfurt, Hessen, Germany

No relationships to disclose
Wojtek Wojakowski, MD, PhD

Chief Division of Cardiology and Structural Heart Diseases
Medical University of Silesia

No relationships to disclose

Disclosure(s):

Raoul I. Bonan, MD, FSCAI: Open Stent Solution: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Stock-privately held company (Ongoing)

Yair Feld, MD, PhD: No financial relationships to disclose

Steven L. Goldberg, MD, FSCAI, FACC: Abbott Labs: Consultant (Ongoing); Boston Scientific, Cardiac Dimensions, Cardiac Success, Cardimed, Cardionovum, Celonova, Contego, Coramaze, Croivalve, CSL Behring LLC, CVRx, Dinova, Endobar, Endologix, Endomatic, Esperion Therapeutics, Inc., Hangzhou Nuomao Medtech: Consulting Fees (e.g., advisory boards) (Ongoing)

Jeff W. Chambers, MD, FSCAI, FACC: No financial relationships to disclose

Georges Ephrem, MD, MSc, FACP, FACC, FSCAI: No financial relationships to disclose

Nicolo Piazza, MD, PhD: No financial relationships to disclose

Ramon Quesada, MD, FACP, FACC, FSCAI: Abbott Labs: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BSC: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Michael J. Reardon, MD: BSCI: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); High Life: Consulting Fees (e.g., advisory boards) (Ongoing); JValve: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Siemens: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); W. L. Gore and Associates, Inc.: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Toby Rogers, MD, PhD: Abbott: Consulting Fees (e.g., advisory boards) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Transmural Systems, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing)

Horst Sievert, MD, FSCAI, FACC, FESC: Abbott, Ablative Solutions, Adona Medical, Akura Medical, Ancora Heart, Append Medical, Axon, Bavaria Medizin Technologie GmbH, BioRefine, Bioventrix, Boston Scientific, Canon, Cardiac Dimensions, Cardiac Success, Cardimed, Cardionovum, Contego: Study honoraria to institution, travel expenses, consulting fees (Ongoing); Coramaze, Croivalve, CSL Behring LLC, CVRx, Dinova, Endobar, Endologix, Endomatic, Esperion Therapeutics, Inc., Hangzhou Nuomao Medtech, Holistick Medical, Intershunt, Intervene, K2, Laminar, Lifetech: Study honoraria to institution, travel expenses, consulting fees (Ongoing); Magenta, Maquet Getinge Group, Metavention, Mitralix, Mokita, Myotec, Neurotronic, Novelrad, NXT Biomedical, Occlutech, Recor, Renal Guard, Shifamed, Terumo, Tonic Medical: Study honoraria to institution, travel expenses, consulting fees (Ongoing); Trisol, TruLeaf, Vascular Dynamics, Vectorious Medtech, Venus, Venock, Vivasure Medical, Vvital Biomed, Whiteswell, Xenter: Study honoraria to institution, travel expenses, consulting fees (Ongoing)

Wojtek Wojakowski, MD, PhD: No financial relationships to disclose